NASDAQ: XBIT · Life Sciences · 4 alerts · CIK 1626878
Share price
$1.85Close, Nov 16
Market cap
$56.4M
Shares outstanding
30.49MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All XBiotech Inc. filings on SEC EDGAR ↗
John Simard, Director, bought 70,000 shares of XBiotech Inc. at $2.05 a share, worth $143K in total on Nov 3, 2026. Shares held after the trade: 4,261,690 (+1.7%).
XBiotech Inc. reported a net loss of $16.7 million for the first nine months of 2026, a slight improvement from the $18.6 million loss in the prior year period. The company's cash position decreased to $105.0 million as of September 30, 2026, while operating expenses were reduced by approximately 32% year-over-year.
John Simard, Director, bought 368,524 shares of XBiotech Inc. at $1.93 a share, worth $711K in total on Oct 26, 2026. Shares held after the trade: 4,191,690 (+9.6%).
XBiotech has appointed Dr. Sushma Shivaswamy and Jan-Paul Simard as Co-Chief Executive Officers, effective October 23, 2026. Dr. Shivaswamy will maintain her $750,000 annual salary, while Jan-Paul Simard entered into a new employment agreement with a $150,000 base salary and a one-time grant of 2,000,000 stock options vesting over three years.